These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1460654)

  • 1. Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome.
    Kishore K; Rattan A; Bagga A; Srivastava RN; Nath NM; Shriniwas
    J Med Microbiol; 1992 Dec; 37(6):364-7. PubMed ID: 1460654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic.
    Bielaszewska M; Janda J; Blahová K; Feber J; Potuzník V; Soucková A
    Clin Nephrol; 1996 Jul; 46(1):42-4. PubMed ID: 8832150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe.
    Chart H; van der Kar NC; Tolboom JJ; Monnens LM; Rowe B
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):707-9. PubMed ID: 7694851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
    Paton AW; Voss E; Manning PA; Paton JC
    Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological identification of infection by verocytotoxin-producing Escherichia coli.
    Chart H; Cheasty T; Rowe B
    Lett Appl Microbiol; 1996 Nov; 23(5):322-4. PubMed ID: 8987714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.
    Caprioli A; Luzzi I; Rosmini F; Pasquini P; Cirrincione R; Gianviti A; Matteucci MC; Rizzoni G
    J Infect Dis; 1992 Jul; 166(1):154-8. PubMed ID: 1607689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.
    Yamada S; Kai A; Kudoh Y
    J Clin Microbiol; 1994 Apr; 32(4):955-9. PubMed ID: 8027349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Four cases of hemolytic uremic syndrome (HUS) associated with serotype O165 verotoxin producing Escherichia coli (VTEC) identified by LPS-solid phase enzyme-linked immunosorbent assay (ELISA)].
    Uchida H; Kanegane H; Yoshiya K; Kitamura K; Ihara T; Kamiya H; Kobayashi Y; Miyazawa H; Takeda T
    Kansenshogaku Zasshi; 1995 Jun; 69(6):678-83. PubMed ID: 7616014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome.
    Morooka T; Matano H; Umeda A; Oda T; Amako K; Karmali MA
    Acta Paediatr Jpn; 1995 Aug; 37(4):469-73. PubMed ID: 7572147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.
    Bitzan M; Ludwig K; Klemt M; König H; Büren J; Müller-Wiefel DE
    Epidemiol Infect; 1993 Apr; 110(2):183-96. PubMed ID: 8472763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
    Karmali MA; Petric M; Lim C; Fleming PC; Arbus GS; Lior H
    J Infect Dis; 1985 May; 151(5):775-82. PubMed ID: 3886804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
    Chart H; Law D; Rowe B; Acheson DW
    J Clin Pathol; 1993 Nov; 46(11):1053-4. PubMed ID: 8254096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
    Yamada S; Matsushita S; Kai A; Sasaki M; Tsuji A; Kanemitsu T; Yamashita N; Anzai E; Kudoh Y
    Microbiol Immunol; 1993; 37(2):111-8. PubMed ID: 8502176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome.
    Ludwig K; Bitzan M; Zimmermann S; Kloth M; Ruder H; Müller-Wiefel DE
    J Infect Dis; 1996 Nov; 174(5):1028-39. PubMed ID: 8896505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.
    Rowe PC; Orrbine E; Lior H; Wells GA; McLaine PN
    Epidemiol Infect; 1993 Feb; 110(1):1-7. PubMed ID: 8432313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.